7.61
-0.41
(-5.11%)
As of 11:02:07 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 24 | 23 |
| Avg. Estimate | 36.19B | 37.23B | 161.87B | 169.72B |
| Low Estimate | 36.19B | 37.23B | 148.67B | 151.71B |
| High Estimate | 36.19B | 37.23B | 171.59B | 183.48B |
| Year Ago Sales | 41.7B | 43.32B | 156.88B | 161.87B |
| Sales Growth (year/est) | -13.21% | -14.05% | 3.18% | 4.85% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STLAMM.XC | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Piper Sandler: Overweight to Neutral | 3/20/2025 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 10/4/2024 |
| Downgrade | Barclays: Overweight to Equal-Weight | 10/3/2024 |
| Downgrade | Jefferies: Buy to Hold | 8/7/2024 |
| Upgrade | Nomura: Neutral to Buy | 7/31/2024 |
| Downgrade | Deutsche Bank: Buy to Hold | 7/29/2024 |